You're not imagining it. And it isn't just age.
Sleep, energy, mood, focus, body composition and libido can all shift as hormones change. FemLab starts by measuring, not guessing — assessment and bloods first, then a plan a doctor stands behind.
What women on hormone therapy report at check-ins.
From patients' own scheduled check-in forms. Real, internal, footnoted.
report better energy, mood or sleep on treatment
report improved mood by their month 2–3 check-in
feel more energetic in the first weeks
find the cream very easy to apply
Patient-reported at scheduled check-ins. Individual results vary. Hormone therapy is prescription-only and doctor-supervised; all medicines carry potential risks and side effects.
Four steps. Bloods included.
Free 3-minute check
Questions about your symptoms and history.
Know your numbers
Your bloodwork, explained in plain language
Your doctor decides
Symptoms and results read together. A doctor may also decline, and will say why.
Reviewed as you go
Delivered discreetly where prescribed, then adjusted at scheduled reviews.
The changes women mention most often.
You may recognise a few of these, or none. They have many possible causes, which is exactly why an assessment comes before any conclusion.
Women's hormones move in stages, not a straight line.
This is the clearest difference from men's hormone care. Levels can fluctuate widely month to month, so where you are in the transition changes what should be measured and what should be considered.
Symptoms can appear years before cycles change. Timing of bloods within your cycle matters here.
The most variable stage. A single blood result can be misleading, so symptoms carry real weight in the assessment.
Twelve months without a period. Priorities often shift towards sleep, mood, bone and heart health.
Long-term health becomes the focus. Reviews continue on the same schedule.
Educational only. Stages are not diagnoses and cannot be self-assigned — a doctor determines where you are, and whether any treatment is appropriate. Surgical menopause, early menopause and hormonal contraception all change this picture.
Real reviews from real women.
Femlab
Your questions, answered.
Am I too early — or too late — for this?+
Symptoms can begin years before cycles change and can continue long after they stop. The assessment exists to work out where you are; a doctor will tell you if it is not the right time.
Do I need blood tests?+
Usually yes for hormone pathways, and timing can matter if you are still cycling. Your doctor will confirm what applies to you.
What if I'm on contraception or a hormonal IUD?+
Tell us in the assessment. It affects both how results are interpreted and what is appropriate, so it forms part of the doctor's review.
Is it safe? What about side effects?+
All medicines carry potential risks, side effects and contraindications, and suitability differs from woman to woman. Your doctor discusses this with you before anything starts, and monitors you afterwards.
How soon would I notice a difference?+
It varies, and no timeline can be promised. Our patients report changes at different points and some report none — that is why reviews are scheduled rather than left to chance.
Can I cancel?+
Yes, anytime.
However you're feeling, it's worth checking.
Start with a free 3-minute check, reviewed by a registered doctor. If hormone care isn't right for you, we'll tell you that too.
Sources
References & compliance notes
+
Every factual statement on this page is numbered to a source. Items marked for confirmation must be verified or removed before publishing.
- SAHPRA. Guidelines for Advertisement of Medicines and Health Products, SAHPGL-INSP-RC-07, v2, June 2022. Basis for presenting patient-reported experience separately from medicine efficacy.
- Republic of South Africa. Medicines and Related Substances Act 101 of 1965, General Regulations, Regulation 42(1)–(2). Only non-prescription medicines may be advertised to the public; public information may cover price, name, pack size and strength but may make no reference to the registered indication.
- Health Professions Council of South Africa. General Ethical Guidelines for Good Practice in Telemedicine (Booklet 10). Basis for teleconsultation and doctor registration statements.
- Protection of Personal Information Act 4 of 2013 (POPIA). Basis for the confidentiality statement.
- Reference for hormonal variability across the menopausal transition and the limits of single-timepoint testing — proposed: STRAW +10 staging criteria (Harlow et al., 2012) or an equivalent endorsed by your medical team. [CITATION TO BE CONFIRMED BY MEDICAL TEAM]